There are 9 companies tagged `therapeutic`; raised $425.2M from 53 investors

Biolex Therapeutics raised $156.4M from Dow Venture Capital, Johnson & Johnson Development Corporation, Clarus Ventures, Quaker BioVentures, Bioventures Investors, J.P. Morgan Securities Inc., InterSouth Partners, OrbiMed Advisors, Dogwood Equity, Investor Growth Capital, Mitsui Ventures, Investor Growth Capital, J.P. Morgan Securities Inc., Easton Capital, Quaker BioVentures, Polaris Venture Partners, InterSouth Partners, Mitsui Ventures, Johnson & Johnson Development Corporation, Dow Venture Capital, Polaris Venture Partners, InterSouth Partners, Quaker BioVentures, Johnson & Johnson Development Corporation, Mitsui Ventures, Kitty Hawk Capital, and Johnson & Johnson Development Corporation in 6 rounds.

SEC Biolex Gets $20M From Insiders, Sees Strong Data From Hepatitis C Drug Biolex Therapeutics Completes $60 Million Series D Financing to Accelerate Development of Locteron® in Hepatitis C BIOLEX THERAPEUTICS RAISES $30 MILLION TO ADVANCE ITS HEPATITIS C DRUG CANDIDATE AND OTHER PIPELINE PROGRAMS BIOLEX THERAPEUTICS RAISES $36 MILLION IN VENTURE FINANCING

Accera raised $130.6M from POSCO BioVentures, Inventages Venture Capital Investment Inc., and POSCO BioVentures in 6 rounds.

SEC Accera, Inc.: Series D $11M Accera raises $35M SEC D/A SEC D/A SEC D

EBR Systems raised $61M from SV Life Sciences, Split Rock Partners, Frazier Healthcare Ventures, Delphi Ventures, DeNovo Ventures, Frazier Healthcare Ventures, St. Paul Venture Capital, DeNovo Ventures, and Split Rock Partners in 3 rounds.


GenVault raised $31M from QuestMark Partners, Montagu Newhall Associates, Domain Associates, Cross Creek Capital, QuestMark Partners, and Domain Associates in 2 rounds.

GenVault Corporation Raises $18 Million of Financing

CAPNIA raised $22.2M from Vivo Ventures, Teknoinvest, and Asset Management Company in 4 rounds.

SEC SEC SEC Capnia Secures $12 Million Series B

Everist Health raised $12.5M in 2 rounds.


nLife Therapeutics raised $6.8M from Caixa Capital Risc and Invercaria .

nLife Therapeutics Raises €5M in Funding

Neurotec Pharma raised $4.5M from Inveready Technology Investment Group and Caja Navarra .

Neurotec Pharma Raises €3.3M in Equity Funding

DRO Biosystems raised $237K from Gestión de Capital Riesgo del País Vasco .